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Background: The HIV epidemic in Indonesia is among the fastest growing in Asia and call 
for interventions scaling up. Two current adapted interventions are Voluntary Counselling 
and Testing (VCT) and Provider Initiated Counselling and Testing (PITC). Scaling up these 
two interventions, however, must be analysed using economic evaluation given the limited 
existing budget. Two concerns prevail: 1) there is a question on extending the coverage of 
VCT  through  PITC  which  has  not  been  economically  analysed,  and  2)  the  economic 
evaluation studies on both interventions are limited.  
 
Methods: The cost estimation is based on a previous study on the costs of delivering VCT 
which  is  adapted  to  estimate  the  cost  of  delivering  hospital  based  VCT  and  PITC.  The 
effectiveness study is also adapted from a previous study on the natural decline of CD 4 cell 
count on HIV (+) clients for intravenous drug user (IDU) and non IDU, related to the life 
years saved.  
 
Results: Most clients are on their productive age. The unit cost per HIV (+) detected differs 
by US$37. The time gain of performing VCT compared to PITC for IDU is shorter than that 
of  the  non-IDU.  The  Incremental  Cost  Effectiveness  Ratio  (ICER)  of  performing  VCT 
compared to PITC for unit cost per HIV (+) case is higher for non IDU compared to IDU.  
 
Discussion: VCT has the benefit of early detection compared to PITC. The unit costs of VCT 
and PITC per HIV (+) cases for each service shows higher costs for PITC than VCT. The 
ICER based on unit costs per HIV (+) case for both IDU and non – IDU shows that providing 
VCT will result in less cost in gaining more life years. Although the results show that VCT 
seems to be more cost effective than PITC, the unique characteristics of PITC should also be 
considered. We suggest that PITC may not be best as the scaling up measure replacing VCT, 
but may be best as a complementary.    
 









The HIV epidemic in Indonesia is among the fastest growing in Asia and it is estimated that 
without an acceleration of prevention, people with HIV positive will amount to 482,800 by 
2014 (UNAIDS, 2007; CDC MoH, 2008). From 2004 to 2009, the cumulative number of 
reported AIDS cases has risen from 2,682 to 19,973 cases, whereas the HIV infection cases 
were reported from 16 out of 33 provinces in 2004 and increased to 32 out of 33 provinces in 
2009. Within this period, both injecting drug use and sexual transmission will continue to be 
the main modes of transmission (NAC
1, 2009).  
 
In respond to the above condition, HIV/AIDS control efforts have increased considerably in 
Indonesia in recent years (Siregar et al, 2009), with voluntary counselling and testing (VCT) 
being a key component in the national strategic plan (Afriandi, et al, 2009). VCT offers an 
entry point to treatment of HIV-positive individuals, and is instrumental to prevent the further 
spread  of  the  disease  by  reducing  risk  behaviour  of  tested  individuals  (UNAIDS,  2001). 
Currently, the  number of VCT sites  had  increased  from 25 in 2004 to 547 in  mid 2009 
(NAC
1, 2010). From 2004 to 2007, there had been an increase on VCT delivered to the high 




To complement the ongoing VCT, provider-initiated HIV testing and counseling (PITC) is 
provided to improve the access to care to HIV-infected patients and strengthen the success of 
national  HIV/AIDS  control  efforts.  PITC  refers  to  HIV  testing  and  counseling  which  is 
recommended by health care providers to clients as a standard component of medical care, 
aiming to enable specific clinical decisions to be made and/or specific medical services to be 
performed with the knowledge of the person’s HIV status. PITC also aims to increase the 
number  of  patients  tested,  to  detect  unsuspected  HIV  infected  clients  attending  health 
facilities, and presents an opportunity to ensure that HIV is more systematically diagnosed in 
health care facilities (Leelukkanaveera, et al, 2010; WHO, 2007; Becker et al, 2009). Both 
interventions will be elaborated more later on.  
 
Currently, there are two concerns which relate to the interventions which come from policy 
and academic point of views. The former concern arises because there is an idea on extending 
the coverage of VCT through PITC, so that PITC will not only act as a compliment of VCT. 3 
 
Given the limited budget of HIV/AIDS in Indonesia (Siregar, et al, 2009) and the different 
health condition of clients accessing either service, the scaling up of VCT by replacing it with 
PITC  warrants  economic  investigation  to  explore  whether  this  option  is  economically 
feasible. 
 
The second concern is on academic level, in which although VCT and PITC are important 
interventions, the current economic evaluation study on both interventions in Asia is limited, 
as pointed out by Walker (2003). Currently, the evidence-base on costs of VCT only includes 
two studies in Thailand (Teerawattananon et al 2005; HITAP 2008), one study at the south-
east Asian sub-regional level (Hogan et al 2005), and one in India (Dandona et al 2008). 
Presently, there is only one economic evaluation study comparing VCT and PITC in Asia by 
Leelukkanaveera, et al (2010), which took place in Thailand. In Indonesia, to our knowledge, 
there has not been any research studying the cost effectiveness of VCT and PITC.   
 
This paper tries to address these concerns by conducting a cost effectiveness study comparing 
VCT and PITC in Indonesia mainly based on their number of HIV (+) cases detected and 
early detection benefit. This study is unique for two reasons. First, it provides the first of such 
study in Indonesia, which is an important input for rational decision-making on the scaling up 
of  service  delivery  (Siregar  et  al,  2009).  Secondly,  the  study  also  estimates  the  relevant 
program costs, which are typically ignored in economic analysis (Johns et al, 2003), and 
estimates the costs of clients of seeking and undergoing VCT and PITC. Both program costs 





The  study  combines  the  results  of  a  study  by  (Siregar  et  al,  2010)  and  (Meijerink, 
unpublished) under IMPACT project, plus results from own research. IMPACT project is a 
collaboration  between  one  university  in  Indonesia  (Universitas  Padjadjaran)  and  three 
European universities. All studies are conducted at clinics located at and related with Hasan 
Sadikin hospital, a teaching and provincial top-referral public hospital for West Java (with a 
population  of  approximately  40  million  people).  The  clinics  studied  are  hospital  clinic, 
Methadone Maintenance Treatment (MMT) clinic, and a prison based clinic (which conduct 
all HIV-related services in collaboration with Hasan Sadikin hospital).     4 
 
Study Sites 
Hospital clinic (Teratai clinic) 
The clinic resides  in Hasan Sadikin  hospital delivers HIV related services such  as VCT, 
PITC, ART (antiretroviral treatment), and STI (sexually transmitted infection) services, and 
general medical services, and is frequented by both the general population and all kind of 
high risk groups, mostly IDUs. The number of HIV service related visits is very high and the 
clinic is currently operates at full capacity. The clinic generates its own revenues through 
user-fees  and  otherwise  relies  on  government,  hospital  and  donor-funding.  This  clinic  is 
included in both studies by Siregar, et al (2010) and Meijerink, et al (unpublished). 
 
MMT clinic 
The MMT clinic resides in Hasan Sadikin hospital, was established in May 2006 and has 
been running up to now. The clinic is one of the 24 MMT service points across the country 
and opens everyday from morning to noon. The clinic works closely with the HIV clinic in 
the hospital. This clinic is included in the study my Meijerink, et al (unpublished).   
 
Prison clinic 
This clinic resides at a prison for drug users, including IDUs. All of the tests and HIV related 
services  are  delivered  in  collaboration  with  Hasan  Sadikin  hospital.  The  HIV  test  are 
conducted at Hasan Sadikin hospital, and HIV (+) prisoners receive ART from the hospital as 
well.  This  clinic  is  included  in  the  study  by  Siregar,  et  al  (2010)  and  Meijerink,  et  al 
(unpublished).   
 
The Interventions 
Voluntary Counseling and Testing (VCT)  
VCT offers an entry point to treatment of HIV-positive individuals, and is instrumental to 
prevent  the  further  spread  of  the  disease  by  reducing  risk  behavior  of  tested  individuals 
(UNAIDS, 2001). Traditional VCT focuses on walk-in clients and offers an individualized 
counseling session, tailored to personal risk behaviors. The nature of VCT is voluntary and 
confidential, only shared between the counselor and the people undertaking the procedure. 
Someone has undertaken VCT if he/she has followed the whole procedures, namely pre test 
counseling, HIV test, and post test counseling. Counseling is defined as professional advices 
and suggestions given to an individual with problems, delivered by counselors, who are staff 
with the ability of counseling and comprehensive understanding of HIV/AIDS. The post test 5 
 
counseling  specifically  focuses  on  risk  reduction  and  ’positive  living”,  regardless  of  the 
results (Surdo, 2007; RSHS, 2008).  
 
The aim of VCT is, first, to help the individuals in risk of HIV or PLWHA (people living 
with HIV/AIDS) to have healthier and safer behavior through psychological support to the 
individual and related family members. Second, VCT is aimed to reduce the risk of infection 
through sharing the information of risky behavior and to assist developing personal abilities 
to support health lifestyle. Last, VCT is also aimed to ensure effective and early treatment 
(RSHS, 2008). The following figure describes the VCT procedure in Teratai clinic in Hasan 
Sadikin Hospital. 
 
Figure 1. VCT Procedure in Hasan Sadikin Hospital 
 
Adapted from Hasan Sadikin Hospital Bandung VCT Procedure (2008) 
 
Provider Initiated Counseling and Testing (PITC) 
To complement the ongoing VCT, provider-initiated HIV counseling and testing (PITC) is 
provided to improve the access to care for HIV-infected patients and strengthen the success 
of national HIV/AIDS control efforts. PITC refers to HIV testing and counseling which is 
recommended by health care providers to clients as a standard component of medical care, 
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diagnostic testing, and/or routine offer. It is aiming to enable specific clinical decisions to be 
made and/or specific medical services to be performed with the knowledge of the person’s 
HIV status since providers  need HIV diagnosis  in order to provide quality care  for their 
patients. The intervention also aims to increase the number of patients tested, to perform early 
detection and detect unsuspected HIV infected clients attending health facilities, and presents 
an opportunity to ensure that HIV is more systematically diagnosed in health care facilities 
(Leelukkanaveera, et al, 2010; WHO, 2007; Becker et al, 2009; Surdo, 2007; RSHS, 2008). 
Figure 2 describes the procedure of PITC in Hasan Sadikin Hospital.  
 
Figure 2. PITC Procedure in Hasan Sadikin Hospital 
      
Adapted from Hasan Sadikin Hospital Bandung PITC Procedure (2008) 
 
Cost Estimation 
The costs estimation of delivering VCT in a hospital clinic is derived and adapted from a 
research by Siregar et al (2010). The research estimates the costs of VCT in four different 
settings, namely hospital clinic, community HIV clinic, community STI clinic, and prison 
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clinic. We took the results on VCT costs in the hospital clinic into our analysis. This has 
included health care costs (costs related to the consumption of resources in the health care 
system), and non-health care costs (costs falling on the patient for seeking and undergoing 
care) of delivering hospital based VCT service.  
 
As such, the health care costs for PITC are calculated by using similar method with the study 
by Siregar, et al (2010) and also a study by Afriandi, et al (2009) which incorporates micro 
costing (Drummond, et al, 2005). Relevant health care costs were estimated on the basis of 
service utilization and service cost data. The data on service utilization were retrieved from 
the hospital clinic’s records including information on number of PITC and resources used. 
All  resources  consumed  and  salaries  were  listed  and  estimated  on  the  basis  of  clinical 
records, interviews with medical staff, government standard, or market price. Costs to the 
clinic consist of recurrent and capital costs. Personnel recurrent costs were estimated on the 
basis of their actual wage or estimated by using government salary scales (issued by Ministry 
of Finance in 2007). Other recurrent costs such as the cost of medical and administration 
goods consumed during the one year period of observation were estimated using both actual 
and market prices. Laboratory cost was estimated using the current service charge. Capital 
costs, which include trainings and workshops attended by the clinic staff, were obtained from 
their actual budget or government records. Market prices were used to estimate other capital 
costs, which include the cost of equipment, furniture, as well as start-up costs. Capital costs 
were subsequently annualized on the basis of the life time of the capital items. The costs of 
utilities were omitted (i.e. water, electricity).  
 
Non-health  care  costs  (i.e.  patient  costs)  for  PITC  were  estimated  based  on  the  results 
obtained from the study by Siregar, et al (2010) as the socio-economic characteristics of the 
clients utilizing VCT and PITC are roughly similar. The patient costs information collected 
were, among others, demographic characteristics, travel costs, travelling time, the monthly 
income of the client, the average number of daily working hours, and monthly expenditures. 
All costs were measured in Rupiah, and converted to US$ using the current exchange rate 
(IMF, 2010).  
 
Effectiveness Measurement 
The effectiveness measurement were calculated based on the model developed by Meijerink 
et al (unpublished) using the CD4 cell count data for clients utilizing VCT or PITC. The 8 
 
model predicts the natural decline of CD 4 cell count on an HIV positive person (without 
treatment) for either IDU or non-IDU given their CD 4 cell count during time of HIV testing. 
Data were derived from a cohort of 1464 unselected HIV-infected patients attending three 
urban clinics mentioned previously between August 2007 and August 2010. 
 
HIV antibodies are measured using different commercially available rapid tests. The hospital 
laboratory also uses immunoassays, with external quality control showing 100% accuracy 
(National Serology Reference Laboratory, Australia). CD4 cell measurements are performed 
at  the  hospital  laboratory  using  Facscount  flowcytometry  (BD  Biosciences,  Jakarta, 
Indonesia). 
 
The Effectiveness Modeling (Study by Meijerink, et al) 
The effectiveness measurement were calculated based on the model developed in a study 
conducted  by  Meijerink  et  al  (unpublished)  using  the  CD4  cell  count  data  for  clients 
attending the hospital clinic. The model predicts the natural decline of CD 4 cell count on an 
HIV positive person for either IDU (Injecting Drug User) or non-IDU given their CD 4 cell 
count during the time of HIV testing. The decline of CD4 cell numbers is used as it is a very 
accurate and meaningful parameter to monitor the natural course of HIV infection. 
 
All adults (≥16 years) presenting with HIV infection between August 2007 and August 2010 
who had not yet been exposed to ART were selected in the study. For the linear mixed model 
to describe the natural decline of CD4 cells over time, all patients who had subsequent CD4 
cell counts measured at least one month apart were included. To meet all criteria for linear 
regression all CD4 cell counts were transformed to the square root scale. The effect of IDU 
on the decline of CD4 cells was determined with an interaction-term between IDU and time 
(IDU*t). A constant variable was added to the model to account for the variability in CD4 
cell decline which is independent of other variables. The correlation between CD4 cell counts 




This model predicts that a decline from 350 to 200 CD4 cells/µl would take an average of 20 
months in patients with a history of IDU, compared with 38 months in patients without a 
history of IDU (18  months difference). This  indicates that people  with  a  history of IDU 
progress 1.9 times faster from 350 to 200 CD4 cells/µl. The study, however, is limited by the 9 
 
fact that half of our patients only had two CD4 counts measured. Despite these limitations, 
this study by Meijerink, et al can still conclude that IDU accelerates the natural decline of 
CD4  cells  in  HIV-infected  patients.  The  findings  indicate  that  HIV  disease  progression 
should be monitored carefully in IDUs and that earlier initiating of ART should be considered 
for this risk group.  
 
Application in the Current Study 
We used the model to determine the length of time of natural CD 4 cell count decline for 
VCT and PITC clients. We gave the CD 4 cell count of VCT and PITC clients on our study to 
the Meijerink et al model’s maker, and they gave us the estimated CD 4 cell count natural 
decline for these clients.  
 
We used these results to show the time gained if a client detected earlier which is showed by 
higher CD 4 cell count during HIV testing. We expected that this can show the benefit of 
having  early  detection  (by  having  more  CD  4  cell  count  and  life  years  left),  or  the 
disadvantage of having late detection  (by having less CD 4 cell count and less life years left). 
As such, this approach can show the onset of early detection on both VCT and PITC. We 
provided the CD 4 cell count for VCT clients from Wisaksana et al (2009), and the CD 4 cell 
count for PITC as derived from own calculation.  
 
We then calculate the Incremental Cost Effectiveness Ratio (ICER) for unit cost per service 
performed and unit cost per HIV (+) case. We based our calculation on the difference of total 
costs divided by time of years gained. As the model differentiates between the time gain for 
IDU and non-IDU, we have two results for the two approaches. 
 
Results 
Table 1 summarizes the characteristics of the sampled clients accessing HIV counselling and 
testing  services  at  the  hospital  clinic.  Most  clients  were  on  their  productive  age  and 
employed. Most are utilizing public transport to access the clinic and the average travelling 
time is 45 minutes. Clients spent 94 minutes in the clinic to queue and utilize the service. 





Table 1. Characteristics of clients utilizing HIV counseling and testing services at the hospital clinic 
Variable     Hospital clinic (n=66)  
       
Male, no.     37 (56%) 
Age, mean    28 
Occupation, no.      
  Employed     58 (93%)
 † 
  Unemployed and/or not in labor force    4 (7%)
 † 
Mode of transportation to clinic, no.      
  Public transport    33 (50%) 
   Motorcycle    29 (44%) 
  Others    4 (6%) 
Travelling time to the clinic, minutes, mean     45 
Spent time at the clinic, minutes, mean    94 
Client’s monthly estimated income, USD (median)     48 (36 – 72)
††  
† Data were available for 62 subjects. 
†† Data were available for 63 subjects. 
 
The costs, utilization, and CD 4 cell count variables of VCT and PITC are summarized in 
Table  2.  The  utilization  of  PITC  is  less  then  VCT  and  so  does  the  number  of  HIV  (+) 
detected. The median of CD 4 cell count of VCT clients are far above the median of CD 4 
cell count of PITC clients, while the one year total costs (including non health-care costs) of 
clients utilizing VCT are approximately triple that of PITC clients. The unit cost per service 
performed, however, does not differ significantly between the two services. The unit cost per 
HIV (+) detected between the two services differs by US$37.   
 
Table 2. Summary of Costs and Utilization  
Variable  VCT
  PITC 
Number of Service Performed  421  147 
HIV (+) detected, no.  167  47 
CD 4 cell count on HIV (+) (/mm
3)  129 (26 – 338)
†  9 (1 – 184)
†† 
One Year Service Costs (US$)  33,455  11,233 
Unit Cost per Service Performed (US$)  79  76 
Unit Cost per HIV (+) case (US$)  191  228 
† median (IQR) 
†† median (min – max) 




Table 3 presents the time gained and ICER, divided into IDU and non-IDU. The logic of time 
gained is as follows. The CD 4 cell count median of clients who took VCT is 129 cells/µl, 
where as those who undergone PITC were having the CD 4 cell count median of 9 cells/µl. 
By using Meijerink, et al  model, the  length of  time required  for the CD 4 cell count to 
naturally decline from 129 cells/µl to 9 cells/µl is two years for IDU, and around three years 
for non-IDU. Applying this logic into our study, it can be interpreted that for IDU applying 
VCT will save two years of their CD 4 cell count natural decline before it reaches the level 
where clients usually take PITC. For non-IDU, VCT will save around three years of their CD 
4 count natural decline before it reaches the level where clients usually take PITC. The ICER 
for unit cost per service performed is higher for IDU compared to the non-IDU. The opposite 
applies to the ICER for unit costs per HIV (+) case. 
 
Table 3. Time gained and Incremental Cost Effectiveness Ratio (ICER) 
 
Time gained for doing VCT instead  of PITC based on  CD 4 cell count 
IDU  2 years 
Non – IDU  3.2 years 
ICER (US$/year gain)    
based on unit costs per service performed   
IDU  1.52 US$/life years gain 
Non – IDU  0.96 US$/life years gain 
based on unit costs per HIV (+) case    
IDU  -18 US$/life years gain 
Non – IDU  -12 US$/life years gain 
 
Discussion 
Although both VCT and PITC are utilized in the hospital clinic, their cost effectiveness has 
not been measured in Indonesia. This paper addresses this gap and tries to provide policy 
relevant information.  
 
Clients utilizing HIV counseling and testing in the hospital clinic are on their productive age. 
As such, early detection becomes crucial to hinder or delay loss of productivity as early as 
possible. From this respect, it is clearly seen that VCT clients are utilizing the service at 
earlier stage of HIV then those who access PITC based on their CD 4 cell count which is a lot 
higher than clients undergone PITC (129 cells/µl compared to 9 cells/µl). Therefore, VCT 
has the benefit or early detection compared to PITC. This is reasonable because currently the 12 
 
PITC clients came to the hospital when they suffered from late and/or complicated cases as 
their main reason to visit hospital, and not for HIV testing. At PITC clients level of CD 4 cell 
count (9 cells/µl), it is expected that the clients suffer from severe opportunistic infection and 
relatively high frequency of complications (Barlett & Gallant, 2007), and, as such, requires 
more medical treatment and incurs more costs. 
 
VCT  service  costs  in  one  year  is  approximately  triple  the  costs  of  PITC,  amounting  to 
US$33,455. This is understandable since VCT is utilized by more clients. However, dividing 
the total costs by number of service utilization resulted in only a US$3 difference of unit cost 
per service. Furthermore, dividing VCT and PITC total costs by the number of HIV (+) cases 
for each service resulted in an opposing PITCure. In this respect, the unit cost per HIV (+) is 
higher for PITC than VCT. In this case, and combining with the benefit of early detection, 
VCT seems to be more cost effective than PITC.  
 
Exploring the time gained results, we can derive an important conclusion. As VCT detects 
HIV (+) clients at much higher CD 4 cell count than PITC, providing VCT will give a certain 
amount of estimated time gain for the client. In other words, detecting HIV (+) clients at 
earlier stage (higher CD 4 cell count, where clients usually take VCT) will give the clients 
more time to be treated before they reach the late stage of the disease (lower CD 4 cell count, 
where clients usually take HIV test) which is more severe. To this extent, utilizing VCT 
seems to result in more time gain compared to PITC, namely two years for IDU and around 
three years for non-IDU.  
 
We then combined the time gained results with the costs data to calculate the ICER for IDU 
and non-IDU. The ICER based on unit costs per service performed is relatively low for both 
IDU and non – IDU. It means that spending more money on VCT might be more appropriate 
given the relatively low cost to the society and the benefit of life years gained. The ICER 
based on unit costs per HIV (+) case  for  both IDU and  non – IDU gives an  interesting 
finding. Leaning on VCT in this respect will actually result in less cost in gaining more life 
years. This finding suggests that performing VCT actually reduce the costs to the society in 
gaining  a  life  year.  This  latter  finding,  however,  may  need  further  research  to  confirm 
whether this is indeed the case.       
 13 
 
All of the findings in this paper indicate that VCT seems to be more cost effective than PITC. 
However, the unique characteristic of PITC should also be taken into account. It is important 
to note that the first step of PITC is performed by physicians through diagnosis. Clients 
utilizing PITC might be those who suffer from opportunistic infections occur during the later 
stage of HIV/AIDS and visit the physicians for consultation without realizing that they may 
have already been HIV infected. Thus, these clients may not access HIV testing if they are 
not  advised  by  the  physicians  to  take  PITC  (or,  in  some  cases,  VCT).  This  unique 
characteristic emphasizes the existence of PITC as a complement to the earlier established 
VCT and should be maintained, even if PITC is less cost effective. However, scaling up VCT 
by replacing it with PITC should be conducted with care and may need further and proper 
analysis. 
 
Our results should be interpreted with some cautions. First, this study has evaluated highly 
contextualized  VCT  and  PITC  service  delivery  models,  which  may  hamper  their 
generalizibility. Yet, the conceptual decision  framework can  be applied to other settings. 
Second, we estimated patient costs of seeking and undergoing care on the basis of (assumed) 
productivity losses –we may then have overestimated the total patient costs. Third, personnel 
costs in clinics may include inefficiencies in the delivery of VCT and PITC services, and we 
may have overestimated total costs - a time motion study is warranted to assess the more 
exact required resources to scale up VCT and PITC services. Fourth, the effectiveness model 
is based on the data of clients utilizing HIV counseling and testing in the hospital clinic 
which  refer  to  both  VCT  and  PITC.  Developing  a  specific  model  for  each  service  may 
generate  more  appropriate  results.  Fifth,  there  might  be  bias  in  client  selection.  Further 
research applying randomized sample selection in clinics serving VCT and PITC separately 
may result in better outcome.     
 
In  conclusion,  we  recommend  the  current  government  policy  in  Indonesia  of  performing 
PITC as a complement to VCT to be  maintained. As of now, this seems to be the  most 
appropriate approach, given the current HIV epidemic situation in Indonesia. Replacing VCT 
with PITC within the context of scaling up seems to be a less favorable option, although 
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